UKCGG responses to guidance from other bodies

Breast Cancer Surveillance in Patients with NF1

Please read the UKCGG statement on recommendations for breast surveillance in patients with Neurofibromatosis type 1

UKCGG response to latest ALDO publication (Philpott et al, J Med Gen 2022)

Please click the link below to see our statement in response to the recent publication by Philpott et al in the Journal of Medical Genetics (available here).

UKCGG response to NICE guidance NG85

NICE released guidance on the diagnosis and management of pancreatic cancer in adults in 2018 [NG85], which is available to review here.

UKCGG, in collaboration with other bodies, including InSiGHT, has some concerns about the recommendations for screening in familial pancreatic cancer.

The UKCGG released a statement regarding these guidelines in October 2018, which is available to download here below, as are comments made by UKCGG on the guidance at the time.